Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Eldofer is a branded generic hematinic supplement marketed by El-Dorado Biotech (Eldora). It is a combination product typically formulated with Ferrous Ascorbate and Folic Acid (Vitamin B9). Ferrous Ascorbate is a synthetic conjugate of ascorbic acid and ferrous iron, designed to provide high bioavailability and reduced gastrointestinal side effects compared to other iron salts. It serves to replenish iron stores necessary for the production of hemoglobin, which is essential for oxygen transport in the blood. Folic Acid is included to support erythropoiesis and nucleoprotein synthesis, and it is particularly critical during pregnancy to prevent neural tube defects in the developing fetus. Eldofer is primarily indicated for the treatment and prevention of iron deficiency anemia and as a nutritional supplement during pregnancy and lactation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Eldofer.